KISHORCHANDRA GONSAI: Open Payments
NPI 1043308760 · WEST HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 24 payments from 8 companies in 2025. Trend: 2023 $516 · 2024 $885 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $191 |
| Almatica Pharma LLC | 6 | $106 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: VRAYLAR, LOREEV XR, Auvelity, TRINTELLIX, COBENFY, REXULTI, INGREZZA, CAPLYTA.
Industry payments across CT — which companies pay providers there.
